Severe Malaria
Showing 26 - 50 of >10,000
Malaria Fever Randomized Controlled Trial (RCT)
Enrolling by invitation
- Brain Injuries
- +5 more
- Aggressive antipyretics therapy of fever vs usual care in the Malaria RCT study
-
Blantyre, Southern, Malawi
- +1 more
Feb 16, 2023
Malaria,Falciparum Trial (Artemisia afra or Annua 10g oral infusion/tea per day for 14 days)
Not yet recruiting
- Malaria,Falciparum
- Artemisia afra or Annua 10g oral infusion/tea per day for 14 days
- (no location specified)
Mar 23, 2023
Malaria, Vivax, Malaria Trial in Lima (Focal Mass Drug Administration (fMDA))
Not yet recruiting
- Malaria, Vivax
- Malaria
- Focal Mass Drug Administration (fMDA)
-
Lima, PeruUniversidad Peruana de Cayetano Heredia
Jan 18, 2023
Host and Parasite Factors That Influence Susceptibility to
Recruiting
- Malaria
-
Bamako, Mali
- +1 more
Jan 18, 2023
Malaria Trial in Oshogbo (Perennial Malaria Chemoprevention effect)
Active, not recruiting
- Malaria
- Perennial Malaria Chemoprevention effect
-
Oshogbo, Osun, NigeriaMinistry of Health
Nov 30, 2023
Malaria, Malaria, Vivax, Plasmodium Vivax Malaria Trial in Mae Sot (Dihydroartemisinin-piperaquine plus tafenoquine (450 mg
Not yet recruiting
- Malaria
- +2 more
- Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose)
- Chloroquine plus Tafenoquine (450 mg adult dose)
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Mar 15, 2023
TES of Artemether-lumefantrine for Pf in the Philippines in 2015
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Malaria,Falciparum, Children, Only Trial in Ouagadougou, Bamako (RABIPUR®, RTS,S/AS01, SMC with SP+AQ)
Completed
- Malaria,Falciparum
- Children, Only
- RABIPUR®
- +3 more
-
Ouagadougou, Burkina Faso
- +1 more
Mar 14, 2022
Strengthening Evidence for Policy on RTS,S/AS01 Malaria Vaccine
Active, not recruiting
- Malaria
- Case-control study of clinical outcomes
- Case-control study of mortality outcome
-
Kintampo, Ghana
- +3 more
Sep 10, 2021
Vivax Malaria, G6PD Deficiency Trial in Hanura, Labuhanbatu, Mimika (Revised case management package)
Not yet recruiting
- Vivax Malaria
- G6PD Deficiency
- Revised case management package
-
Hanura, Lampung, Indonesia
- +5 more
May 18, 2023
Malaria in Pregnancy Trial in Kinshasa (Sulfadoxine pyrimethamine, Pyramax)
Active, not recruiting
- Malaria in Pregnancy
- Sulfadoxine pyrimethamine
- Pyramax
-
Kinshasa, Congo, The Democratic Republic of theMaternité Esengo
Jul 7, 2022
ERASE - Impact of COVID-19 on Malaria Control
Not yet recruiting
- Malaria
- Malaria in Pregnancy
- Advanced Analysis of Polymorphism
- (no location specified)
Apr 25, 2022
Sickle Cell Anemia in Children, Malaria Trial in Blantyre, Jinja, Kitgum (Dihydroartemisinin Piperaquine)
Active, not recruiting
- Sickle Cell Anemia in Children
- Malaria
- Dihydroartemisinin Piperaquine
-
Blantyre, Malawi
- +2 more
Sep 5, 2022
Malaria Trial in Ouagadougou (Sulphadoxine-Pyrimethamine/Amodiaquine, Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM))
Not yet recruiting
- Malaria
- Sulphadoxine-Pyrimethamine/Amodiaquine
- Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)
-
Ouagadougou, Burkina FasoMalaria Consortium
Jul 7, 2023
Impact of Malaria on Pregnant Women in Ouelessebougou, Mali
Completed
- Malaria
-
Bamako, MaliOuelessebougou Clinical Research Center (Malaria Research and Tr
Jan 19, 2023
Malaria Trial in Kumasi, Kisumu (RTS,S/AS01E (Full dose), RTS,S/AS01E (1/5th dose), Rabies vaccine)
Completed
- Malaria
- RTS,S/AS01E (Full dose)
- +2 more
-
Kumasi, Ghana
- +1 more
Jan 24, 2023
Malaria Trial (In2Care EaveTube)
Not yet recruiting
- Malaria
- In2Care EaveTube
- (no location specified)
Feb 24, 2023
Malaria Trial in Oxford (R21/Matrix-M, Rabies vaccine)
Active, not recruiting
- Malaria
- R21/Matrix-M
- Rabies vaccine
-
Oxford, United KingdomCCVTM, University of Oxford, Churchill Hospital
Jan 26, 2022
Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth Trial in Kinshasa, Eldoret (Malaria High-Sensitivity Rapid
Not yet recruiting
- Malaria,Falciparum
- +8 more
- Malaria High-Sensitivity Rapid Diagnostic Test (HS-RDT)
- Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet
-
Kinshasa, Congo, The Democratic Republic of the
- +1 more
Feb 24, 2023
Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)
Not yet recruiting
- Plasmodium Falciparum Malaria
- DHA/piperaquine and a SLD-PQ
- Study vaccine R21/Matrix-M™
-
Bāndarban, Bangladesh
- +1 more
Sep 28, 2023
Malaria,Falciparum Trial in Sigle (Rabies vaccine, RH5.1 10µg adjuvated with 50µg Matrix-M, RH5.2 5µg adjuvated with 50µg
Recruiting
- Malaria,Falciparum
- Rabies vaccine
- +2 more
-
Sigle, Boulkiemdé Province, Burkina FasoInstitut de Recherche en Sciences de la Santé
Apr 3, 2023
Malaria,Falciparum, Malaria Trial in Bagamoyo (Artemether-lumefantrine)
Not yet recruiting
- Malaria,Falciparum
- Malaria
-
Bagamoyo, TanzaniaKiwangwa and Fukayosi clinics
Sep 30, 2022
Malaria Trial in Amudat (Sulfadoxine pyrimethamine and amodiaquine, dihydroartemisinin-piperaquine)
Recruiting
- Malaria
- Sulfadoxine pyrimethamine and amodiaquine
- dihydroartemisinin-piperaquine
-
Amudat, Karamoja, UgandaAmudat
Jul 12, 2022